Skip to main content

navenibart

Generic: STAR-0215·Code: STAR-0215

navenibart: developed by 2 companies · 2 clinical trials tracked.

navenibart evidence translation

What we can confirm

2 tracked trials

What it means

More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about navenibart, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Development Pipeline (3)
CompanyPhase
Astria Therapeutics, Inc. (ATXS)
Healthy Participants
Phase 3
Astria Therapeutics, Inc. (ATXS)
Hereditary Angioedema
Phase 2
BIOCRYST PHARMACEUTICALS INC (BCRX)
Hereditary Angioedema
Phase 3
Clinical Trials (2)

A Phase 3 Trial to Evaluate the Long-Term Safety and Efficacy of Navenibart in Participants With Hereditary Angioedema - ORBIT-EXPANSE

NCT07204938·Phase 3
Enrolling by invitation

Primary endpoint: Incidence of treatment-emergent adverse events (TEAEs)

Interventionalopen145 targetStarted 2025-10Completion 2031-1240 sites · Brazil, Bulgaria, Canada, Czechia…Astria Therapeutics, Inc.

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Navenibart in Participants With Hereditary Angioedema (HAE)

NCT06842823·Phase 3·ATXS
Active, not recruiting

Primary endpoint: Number of time-normalized investigator-confirmed HAE attacks during the 6-month Treatment Period.

InterventionalRandomizedquadruple157 enrolledStarted 2025-03Completion 2027-0650 sites · Australia, Austria, Brazil, Bulgaria…Astria Therapeutics, Inc.

Frequently asked questions

Who is developing navenibart?

navenibart is being developed by Astria Therapeutics, Inc., BIOCRYST PHARMACEUTICALS INC.

How many clinical trials involve navenibart?

BioSniper tracks 2 clinical trials involving navenibart.